Select Medical Holdings Corp 2024年度报告

TABLE OF CONTENTS INDEX TO FINANCIAL STATEMENTS UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Form 10-K ☐ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACTOF 1934 SELECT MEDICAL HOLDINGS CORPORATION Delaware20-1764048(State or Other Jurisdiction of Incorporation or Organization)(I.R.S. Employer Identification Number)4714 Gettysburg Road, P.O. Box 2034Mechanicsburg, PA, 17055(Address of Principal Executive Offices and Zip Code)(717) 972-1100(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Securities registered pursuant to Section 12(g) of the Act:NONE Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes☐No☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes☐No☐ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has beensubject to such filing requirements for the past 90 days. Yes☐No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding twelve months (or for such shorter period that the registrant was requiredto submit such files). Yes☐No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and“emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one): If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complyingwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness ofits internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act by the registered public accounting firm that prepared orissued its audit report.☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrantincluded in the filing reflect the correction of an error to previously held financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-basedcompensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to Section 240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes☐No☐ The aggregate market value of the registrant’s voting stock held by non-affiliates at June 30, 2024 (the last business day of the registrant’smost recently completed second fiscal quarter) was approximately $3,622,619,762, based on the closing price per share of common stock on that dateof $35.06 as reported on the New York Stock Exchange. Shares of common stock known by the registrant to be beneficially owned by directors andofficers of the registrant subject to the reporting and other requirements of Section 16 of the Securities Exchange Act of 1934 are not included in thecomputation. The registrant, however, has made no determination that such persons are “affiliates” within the meaning of Rule 12b-2 under theSecurities Exchange Act of 1934. As of February 1, 2025, the number of shares of Holdings’ Common Stock, $0.001 par value, outstanding was 128,962,850. Unless the context indicates otherwise, any reference in this report to “Holdings” refers to Select Medical Holdings Corporation and anyreference to “Select” refers to Select Medical Corporation, the wholly owned operating subsidiary of Holdings, and any of Select’s subsidiaries. Anyreference to “Concentra” refers to Concentra Group Holdings Parent, LLC (“Concentra Group Holdings Parent”) and its subsidiaries, includingConcentra Inc. References to the “Company,” “we,” “us,” and “our” refer collectively to Holdings, Select, and Concentra. Documents Incorporated by Reference Listed hereunder are the documents, any portions of which are incorporated by reference and the Parts of this Form 10-K into which suchportions are incorporated: 1.The registrant's definitive proxy statement for use in connection with the 2025 Annual Meeting of Stockholders to be held on or about April 30,2025 to be filed within 120 days after the registrant’s fiscal y